
Brian E. Mcdowell
Examiner (ID: 2181, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1622 |
| Issued Applications | 1025 |
| Pending Applications | 135 |
| Abandoned Applications | 522 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11398185
[patent_doc_number] => 20170018722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES'
[patent_app_type] => utility
[patent_app_number] => 15/281480
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10520
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15281480
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/281480 | Materials for organic electroluminescent devices | Sep 29, 2016 | Issued |
Array
(
[id] => 13444011
[patent_doc_number] => 20180273548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => NOVEL MACROCYCLIC SULFONDIIMINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/764283
[patent_app_country] => US
[patent_app_date] => 2016-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39859
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15764283
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/764283 | Macrocyclic sulfondiimine compounds | Sep 25, 2016 | Issued |
Array
(
[id] => 13507597
[patent_doc_number] => 20180305341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => IMIDAZOLINONE DERIVATIVES AS TRPM8 ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 15/758932
[patent_app_country] => US
[patent_app_date] => 2016-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758932
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/758932 | IMIDAZOLINONE DERIVATIVES AS TRPM8 ANTAGONISTS | Sep 11, 2016 | Abandoned |
Array
(
[id] => 13476345
[patent_doc_number] => 20180289715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => POLYMORPHS OF COCRYSTALS OF EPIGALLOCATECHIN GALLATE AND CAFFEINE
[patent_app_type] => utility
[patent_app_number] => 15/756213
[patent_app_country] => US
[patent_app_date] => 2016-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15756213
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/756213 | Polymorphs of cocrystals of epigallocatechin gallate and caffeine | Aug 31, 2016 | Issued |
Array
(
[id] => 11350156
[patent_doc_number] => 20160368896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'INHIBITOR OF p38 MAP KINASE'
[patent_app_type] => utility
[patent_app_number] => 15/253141
[patent_app_country] => US
[patent_app_date] => 2016-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23021
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15253141
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/253141 | Inhibitor of p38 MAP kinase | Aug 30, 2016 | Issued |
Array
(
[id] => 17697083
[patent_doc_number] => 11370793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau
[patent_app_type] => utility
[patent_app_number] => 15/755484
[patent_app_country] => US
[patent_app_date] => 2016-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 90
[patent_no_of_words] => 9731
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755484
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/755484 | Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau | Aug 28, 2016 | Issued |
Array
(
[id] => 11457046
[patent_doc_number] => 20170050952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'NOVEL ANNELATED BENZAMIDES'
[patent_app_type] => utility
[patent_app_number] => 15/241146
[patent_app_country] => US
[patent_app_date] => 2016-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7904
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15241146
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/241146 | Annelated benzamides | Aug 18, 2016 | Issued |
Array
(
[id] => 11323858
[patent_doc_number] => 20160354468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => '(BACTERIO)CHLOROPHYLL PHOTOSENSITIZERS FOR TREATMENT OF EYE DISEASES AND DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/240221
[patent_app_country] => US
[patent_app_date] => 2016-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22167
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15240221
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/240221 | (BACTERIO)CHLOROPHYLL PHOTOSENSITIZERS FOR TREATMENT OF EYE DISEASES AND DISORDERS | Aug 17, 2016 | Abandoned |
Array
(
[id] => 13306977
[patent_doc_number] => 20180205025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => LIGHT EMITTING MATERIAL, MANUFACTURE METHOD THEREOF AND ORGANIC LIGHT EMITTING DIODE USING THE LIGHT EMITTING MATERIAL
[patent_app_type] => utility
[patent_app_number] => 15/122412
[patent_app_country] => US
[patent_app_date] => 2016-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15122412
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/122412 | LIGHT EMITTING MATERIAL, MANUFACTURE METHOD THEREOF AND ORGANIC LIGHT EMITTING DIODE USING THE LIGHT EMITTING MATERIAL | Aug 16, 2016 | Abandoned |
Array
(
[id] => 13300591
[patent_doc_number] => 20180201832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => LIGHT EMITTING MATERIAL, MANUFACTURE METHOD THEREOF AND ORGANIC LIGHT EMITTING DIODE USING THE LIGHT EMITTING MATERIAL
[patent_app_type] => utility
[patent_app_number] => 15/122410
[patent_app_country] => US
[patent_app_date] => 2016-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15122410
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/122410 | Light emitting material, manufacture method thereof and organic light emitting diode using the light emitting material | Aug 16, 2016 | Issued |
Array
(
[id] => 13342701
[patent_doc_number] => 20180222890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => 5-(N-[6,5]-FUSED BICYCLIC ARYL TETRAHYDROISOQUINOLIN-6-YL) PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
[patent_app_type] => utility
[patent_app_number] => 15/749144
[patent_app_country] => US
[patent_app_date] => 2016-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15749144
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/749144 | 5-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication | Aug 9, 2016 | Issued |
Array
(
[id] => 14518881
[patent_doc_number] => 10336687
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Selected amide of Y-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse
[patent_app_type] => utility
[patent_app_number] => 15/750047
[patent_app_country] => US
[patent_app_date] => 2016-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 7
[patent_no_of_words] => 5197
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15750047
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/750047 | Selected amide of Y-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse | Aug 2, 2016 | Issued |
Array
(
[id] => 11866095
[patent_doc_number] => 20170233380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'NOVEL COMPOUNDS AS ROR GAMMA MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/318513
[patent_app_country] => US
[patent_app_date] => 2016-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55385
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15318513
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/318513 | Compounds as ROR gamma modulators | Aug 1, 2016 | Issued |
Array
(
[id] => 11713552
[patent_doc_number] => 20170182049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'NOVEL THERAPEUTICS FOR BRAIN CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/225700
[patent_app_country] => US
[patent_app_date] => 2016-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 87819
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15225700
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/225700 | NOVEL THERAPEUTICS FOR BRAIN CANCER | Jul 31, 2016 | Abandoned |
Array
(
[id] => 15962951
[patent_doc_number] => 20200165227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => 2,4-BIS(NITROGEN-CONTAINING GROUP)-SUBSTITUTED PYRIMIDINE COMPOUND, PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/755572
[patent_app_country] => US
[patent_app_date] => 2016-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25206
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755572
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/755572 | 2,4-bis(nitrogen-containing group)-substituted pyrimidine compound, preparation method and use thereof | Jul 25, 2016 | Issued |
Array
(
[id] => 15962951
[patent_doc_number] => 20200165227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => 2,4-BIS(NITROGEN-CONTAINING GROUP)-SUBSTITUTED PYRIMIDINE COMPOUND, PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/755572
[patent_app_country] => US
[patent_app_date] => 2016-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25206
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755572
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/755572 | 2,4-bis(nitrogen-containing group)-substituted pyrimidine compound, preparation method and use thereof | Jul 25, 2016 | Issued |
Array
(
[id] => 13328425
[patent_doc_number] => 20180215750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => Novel Aminothiazole Compounds and Methods Using Same
[patent_app_type] => utility
[patent_app_number] => 15/746838
[patent_app_country] => US
[patent_app_date] => 2016-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15746838
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/746838 | Aminothiazole compounds and methods using same | Jul 20, 2016 | Issued |
Array
(
[id] => 11121916
[patent_doc_number] => 20160318890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'NOVEL KINASE MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/208984
[patent_app_country] => US
[patent_app_date] => 2016-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 97141
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15208984
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/208984 | Kinase modulators | Jul 12, 2016 | Issued |
Array
(
[id] => 12706711
[patent_doc_number] => 20180127403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => N-ARYL-HYDROACRIDINES AS LIGHT EMITTING ELEMENTS FOR ELECTROLUMINESCENT DEVICES
[patent_app_type] => utility
[patent_app_number] => 15/570578
[patent_app_country] => US
[patent_app_date] => 2016-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570578
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/570578 | N-ARYL-HYDROACRIDINES AS LIGHT EMITTING ELEMENTS FOR ELECTROLUMINESCENT DEVICES | Jul 6, 2016 | Abandoned |
Array
(
[id] => 13300099
[patent_doc_number] => 20180201586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => DEOXYURIDINE TRIPHOSPHATASE INHIBITORS CONTAINING CYCLOPROPANO LINKAGE
[patent_app_type] => utility
[patent_app_number] => 15/741205
[patent_app_country] => US
[patent_app_date] => 2016-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15741205
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/741205 | Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage | Jul 6, 2016 | Issued |